The first generic version of sapropterin has recently received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), and we are currently considering how best to provide advice to Health Boards on whether it should be made available for routine use in NHS Scotland, based on the latest available evidence. Meantime, do...